- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/20 - Nitrogen atoms
Patent holdings for IPC class C07D 241/20
Total number of patents in this class: 594
10-year publication summary
|
36
|
43
|
55
|
58
|
49
|
43
|
38
|
38
|
31
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10883 |
33 |
| Nippon Shinyaku Co., Ltd. | 329 |
30 |
| Medibeacon, Inc. | 136 |
17 |
| Vertex Pharmaceuticals Incorporated | 1598 |
11 |
| Gilead Sciences, Inc. | 2027 |
11 |
| F. Hoffmann-La Roche AG | 7923 |
10 |
| Takeda Pharmaceutical Company Limited | 2708 |
10 |
| Agios Pharmaceuticals, Inc | 217 |
10 |
| Boehringer Ingelheim International GmbH | 4698 |
9 |
| Karyopharm Therapeutics Inc. | 142 |
9 |
| Corteva Agriscience LLC | 2660 |
9 |
| Dana-Farber Cancer Institute, Inc. | 2556 |
8 |
| Incyte Corporation | 1015 |
7 |
| Signal Pharmaceuticals, LLC | 180 |
7 |
| Celgene Quanticel Research, Inc. | 163 |
6 |
| JNC Corporation | 1549 |
6 |
| Neoculi Pty Ltd | 18 |
6 |
| AstraZeneca AB | 2933 |
5 |
| Janssen Pharmaceutica N.V. | 3413 |
5 |
| Arena Pharmaceuticals, Inc. | 367 |
5 |
| Other owners | 380 |